AI Article Synopsis
- HLA-C*01:02:01:70 is a specific variant of the HLA-C gene.
- It differs from the closely related HLA-C*01:02:01:01 allele.
- The difference is due to a single nucleotide change in intron 4 of the gene.
Article Abstract
HLA-C*01:02:01:70 differs from the HLA-C*01:02:01:01 allele by one nucleotide substitution in the intron 4.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/tan.15448 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals.
Vaccine
April 2011
Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
Survivin is a universal tumor antigen that is being currently targeted in vaccine approaches against cancer. Our study here examined the immunogenicity of a novel variant of an HLA-A0201-binding decamer peptide from region 95 to 104 of Survivin (ELMLGEFLKL) with a T→M modification at position 3 in the peptide. We found that this new modified 10-mer peptide had enhanced HLA-A0201 binding and induced a stronger T-cell response over its wild type counterpart peptide (ELTLGEFLKL) in select HLA-A0201(+) normal donors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!